Insights

Speaking Engagement | 06.10.24

“The case of Dimethyl Fumarate,” and “the revision of the EC guidelines on art. 102 TFEU,” 18th Legal Affairs Conference, Dublin

Speaking Engagement | 06.13.23

"The SPC Manufacturing Waiver: the industry stock-taking exercise," and "Regulatory Protection Updates," 17th Legal Affairs Conference, Medicines for Europe, Malta

Speaking Engagement | 11.30.22

“How Value Added Medicines (VAMs) can deliver more accessible off-patent innovation in Europe” 4th Value Added Medicines Conference Medicines for Europe, Brussels

Speaking Engagement | 02.24.22

"Selected IP/IT Topics in a Digital Environment," Crowell & Moring Webinar

Speaking Engagement | 07.30.20

"Global COVID-19 and Sports: Threats and Responses," ILI Webinar

Speaking Engagement | 07.03.20

"Practice Group Effective Dispute Resolution: Resolving disputes caused by the COVID-19 crisis – what options does the in-house lawyer have in the short and longer term?," Webinar in collaboration with IJE/IBJ, Brussels, Belgium

Speaking Engagement | 10.05.17

"The Importance of a Good IP Strategy – What Needs to be Done and Why," IBJ-IJE Seminar, Brussels, Belgium

Speaking Engagement | 03.22.17

“Orphan Drugs and Market Exclusivity," Medicines for Europe, Legal Affaire Conference, London, U.K.

Speaking Engagement | 03.22.17

"Roundtable on UPC Developments," Medicines for Europe, Legal Affaire Conference, London, U.K.

Speaking Engagement | 05.07.15

"The Cross-Border Effect of Foreign Decisions on National Preliminary Injunction Proceedings: a Judicial Prelude to the UPC?" ERA - Litigation and Settlements in Patent Disputes Seminar, Trier, Germany

Speaking Engagement | 03.27.15

"Presumption of Patent Validity in Patent Litigations – The New Trends," 11th EGA Legal Affairs Forum, Brussels, Belgium

Speaking Engagement | 10.15.14

"Content in the Digital Market.," The Brussels Technology Days Conference, Brussels, Belgium

Speaking Engagement | 06.30.14

"Update Belgium," Taylor Wessing European Patent Forum, London

Speaking Engagement | 03.18.14

"Update on Court Cases that Affect the Industry," 10th EGA Legal Affairs Forum, Brussels, Belgium

Speaking Engagement | 03.19.13

"Update on Court Cases that Affect the Industry," 9th EGA Legal Affairs Forum, Brussels, Belgium

Speaking Engagement | 03.23.12

"Update on the Unified Patent Court and the Unitary Patent and Implications for the Industry," 8th Legal EGA Affairs Forum

Speaking Engagement | 11.29.11

"Research exemptions in the US, Europe, Switzerland and Japan," F. Hoffmann-La Roche Ltd and the University of Basel, Basel Intellectual Property Lecture, Basel, Switzerland

Speaking Engagement | 11.24.11

"Sancties en procedures inzake intellectuele rechten: beslag inzake namaak” [Sanctions and procedures in IP matters: saisie-contrefaçon?], BVA - BNVBIE - VSMR Seminar, Brussels

Speaking Engagement | 11.23.11

"Article 10 of the Medicines Act," Confocus Seminar, "Juridische actualiteiten voor de farma-industrie," Antwerp

Speaking Engagement | 03.17.11

"A review of key cases affecting generic companies," 7th EGA Legal Affairs Forum, Brussels